OVARIAN

Clinical trials for OVARIAN explained in plain language.

Never miss a new study

Get alerted when new OVARIAN trials appear

Sign up with your email to follow new studies for OVARIAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug cocktail shows promise for tough cancers

Disease control Ongoing

This study is testing a combination of three drugs—durvalumab (an immunotherapy), olaparib (a targeted therapy), and bevacizumab (a drug that blocks blood vessel growth)—in people with advanced solid tumors, including ovarian, breast, lung, and gastric cancers. The goal is to see…

Matched conditions: OVARIAN

Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC

OVARIAN

Get alerted when new OVARIAN trials appear

New drug cocktail shows promise for tough cancers